Wegovy maker's board shaken up as directors quit
Weight loss drugs Wegovy and Ozempic have propelled Novo Nordisk to be one of the world's most-valuable companies
It's the latest in a raft of changes at the Danish company, which welcomed a new chief executive in August and announced it would lay off 9,000 staff in September.
The departures came about after a disagreement b
Continue Reading on BBC News
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.